Finance

Beta
Lists
000250:KOSDAQ
Sam Chun Dang Pharm Co Ltd
၂၅၃,၅၀၀.၀၀ ₩
-၃.၆၁%
(-၉,၅၀၀.၀၀) 1D
ဇွန် ၁၉, GMT+၉ ၁၅:၃၀:၀၅  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000250...
Open
၂၆၁,၅၀၀ ₩
High
၂၆၆,၅၀၀ ₩
Low
၂၄၅,၅၀၀ ₩
Mkt. cap
ဋေ ၅.၉၅ သိန်း
Avg. vol.
၂.၀၉ သိန်း
Volume
၁.၃၆ သိန်း
Dividend
၀.၀၂%
Quarterly dividend
၁၃ ₩
Ex-dividend date
၂၀၂၅ ဒီ ၂၉
P/E ratio
၅၇၇.၆၈
52-wk high
၁,၂၃၃,၀၀၀ ₩
52-wk low
၁၄၀,၀၀၀ ₩
EPS
၄၃၉ ₩
Shares outstanding
၂.၃၅ ကုဋေ
No. of employees
၄၃၁
Open
၂၆၁,၅၀၀ ₩
High
၂၆၆,၅၀၀ ₩
Low
၂၄၅,၅၀၀ ₩
Mkt. cap
ဋေ ၅.၉၅ သိန်း
Avg. vol.
၂.၀၉ သိန်း
Volume
၁.၃၆ သိန်း
Dividend
၀.၀၂%
Quarterly dividend
၁၃ ₩
Ex-dividend date
၂၀၂၅ ဒီ ၂၉
P/E ratio
၅၇၇.၆၈
52-wk high
၁,၂၃၃,၀၀၀ ₩
52-wk low
၁၄၀,၀၀၀ ₩
EPS
၄၃၉ ₩
Shares outstanding
၂.၃၅ ကုဋေ
No. of employees
၄၃၁
News stories
From sources across the web
Coinfomania
Coinfomania
·
ပြီးခဲ့သည့် ၁ နာရီ
A New Wave for Bitcoin — SEC Approves BTC Index Options for Nasdaq
Insider Monkey
Insider Monkey
·
ပြီးခဲ့သည့် ၂ နာရီ
Is nCino (NCNO) One Of The Stocks Under $20 That Will Explode?
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁၄ နာရီ
QQQY ETF: Near Full Upside Exposure Changes The Investment Case (NASDAQ:QQQY)
About Sam Chun Dang Pharm Co Ltd
CEO-
Employees၄၃၁
Founded၁၉၄၃
Headquarters-
Sector-
Websitescd.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
ဋေ ၅.၆၉ ထ
ဋေ ၅.၈၀ ထ
ဋေ ၆.၆၃ ထ
ဋေ ၆.၄၉ ထ
Cost of goods sold
ဋေ ၃.၁၁ ထ
ဋေ ၃.၁၀ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၃၁ ထ
Cost of revenue
ဋေ ၃.၁၁ ထ
ဋေ ၃.၁၀ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၃၁ ထ
Research and development expenses
၄၅၇.၀၉ ဋေ
၁၀၁.၄၀ ဋေ
၁၇၂.၅၂ ဋေ
၁၆၄.၂၃ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၂.၀၈ ထ
ဋေ ၂.၁၉ ထ
ဋေ ၂.၂၆ ထ
ဋေ ၂.၃၂ ထ
Operating expense
ဋေ ၂.၆၉ ထ
ဋေ ၂.၃၆ ထ
ဋေ ၂.၆၁ ထ
ဋေ ၂.၆၃ ထ
Total operating expenses
ဋေ ၅.၈၀ ထ
ဋေ ၅.၄၆ ထ
ဋေ ၆.၀၉ ထ
ဋေ ၅.၉၄ ထ
Operating income
-၁၀၇.၉၆ ဋေ
၃၄၃.၃၆ ဋေ
၅၃၈.၂၇ ဋေ
၅၄၄.၈၉ ဋေ
Other non operating income
-၁.၈၂ ကုဋေ
-၂.၄၇ ကုဋေ
၄၃.၉၄ ကုဋေ
၃.၅၀ ကုဋေ
EBT including unusual items
-၁၇၂.၀၃ ဋေ
၅၂၅.၀၆ ဋေ
၇၄၃.၃၃ ဋေ
၈၄၃.၄၁ ဋေ
EBT excluding unusual items
-၁၈၉.၀၈ ဋေ
၄၇၁.၂၆ ဋေ
၇၃၂.၉၃ ဋေ
၇၂၃.၄၀ ဋေ
Income tax expense
-၁၀.၅၆ ကုဋေ
၇၈.၉၂ ကုဋေ
-၄၇.၄၇ ကုဋေ
၁၅၂.၈၃ ဋေ
Effective tax rate
၆.၁၄%
၁၅.၀၃%
-၆.၃၉%
၁၈.၁၂%
Other operating expenses
၂၆.၀၈ ကုဋေ
၃၈.၇၃ ကုဋေ
၃၉.၇၉ ကုဋေ
၃၂.၃၂ ကုဋေ
Net income
-၃၃၃.၆၁ ဋေ
၂၅၇.၂၈ ဋေ
၅၅၄.၆၈ ဋေ
၅၄၄.၈၅ ဋေ
Net profit margin
-၅.၈၆%
၄.၄၃%
၈.၃၇%
၈.၄၀%
Earnings per share
-
-
-
-
Interest and investment income
၁၀၈.၃၇ ဋေ
၇၂.၂၆ ကုဋေ
၇၆.၁၈ ကုဋေ
၆၁.၂၂ ကုဋေ
Interest expense
-
-၅၈.၉၈ ကုဋေ
-၆.၁၇ ကုဋေ
-၄၉.၁၉ ကုဋေ
Net interest expenses
၁၀၈.၃၇ ဋေ
၁၃.၂၉ ကုဋေ
၇၀.၀၁ ကုဋေ
၁၂.၀၃ ကုဋေ
Depreciation and amortization charges
၆၉.၄၃ ကုဋေ
၇၀.၇၁ ကုဋေ
၇၀.၉၄ ကုဋေ
၇၁.၈၆ ကုဋေ
EBITDA
၁၉၉.၉၃ ဋေ
၅၆၇.၆၉ ဋေ
၈၅၈.၁၇ ဋေ
၈၆၃.၉၉ ဋေ
Gain or loss from assets sale
-၃.၂၇ ကုဋေ
၃.၇၈ ကုဋေ
-၄၄.၀၉ ကုဋေ
-၃.၅၅ ကုဋေ
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more